Contracts › 75N93020F00003
75N93020F00003: 1800010I Iavi Base Award $810,077 FY20 Cell Line Optimization and Pre-Master Bank Generation for Sb 301, a Vaccine for Hepatitis B Virus (HBV) TOVM20V24VB 2 Iid Can 8470036
Awarded to International Aids Vaccine Initiative Inc. by National Institutes of Health (NIH).
$1.1Mobligated
$1.1Mpotential value
14 May 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93020F00003 |
|---|---|
| Vehicle | 75N93018D00010 |
| Awardee | International Aids Vaccine Initiative Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NY |
| Offers received | 2 |
| Period of performance | 22 September 2020 to 14 May 2028 |
| Potential end | 14 May 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record